Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical
responses in a sizable minority of cancer patients. We found that primary resistance to ICIs …

Background The development of immune checkpoint blockade (ICB) has revolutionized the
clinical outcome of renal cell carcinoma (RCC). Nevertheless, improvement of durability and …

Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1)
blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects …

Limited experimental evidence bridges nutrition and cancer immunosurveillance. Here, we
show that ketogenic diet (KD)—or its principal ketone body, 3-hydroxybutyrate (3HB), most …

Toll-like receptor (TLR) 7/8 ligands act together with radiotherapy and induce profound systemic
antitumor immune reactions coordinated by dendritic cells and executed by natural killer …

The prognosis of colon cancer (CC) is dictated by tumor-infiltrating lymphocytes, including
follicular helper T (T FH ) cells and the efficacy of chemotherapy-induced immune responses. …

Background Beta-herpesviruses are common opportunistic pathogens that cause morbidity
after liver transplantation (LT). Methods Objective of the study was to evaluate the …

Background Impaired immune response has been reported to be the cause of the development
of coronavirus disease 2019 (COVID-19)-related respiratory failure. Further studies are …

Background Prostate cancer (PC) responds to androgen deprivation therapy (ADT) usually
in a transient fashion, progressing from hormone-sensitive PC (HSPC) to castration-resistant …

In addition to local cytotoxic activity, radiotherapy may also elicit local and systemic
antitumor immunity, which may be augmented by immunotherapeutic agents including Toll-like …